0
0
0
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
12/19/2024, 9:05 AM
Summary of Bill HR 7090
Bill 118 hr 7090, also known as the "Clinical Trial Participant Compensation Exclusion Act," aims to amend the Internal Revenue Code of 1986 to exclude certain compensation received by individuals participating in clinical trials from their gross income.
The bill recognizes the important role that clinical trial participants play in advancing medical research and innovation. By excluding compensation received for participating in these trials from gross income, the bill seeks to incentivize more individuals to participate in clinical trials, ultimately leading to the development of new and improved medical treatments and therapies.
Under the provisions of the bill, compensation received by clinical trial participants for their time, travel expenses, and other related costs would not be subject to federal income tax. This would provide much-needed financial relief to individuals who volunteer for these trials and help remove a potential barrier to participation. Overall, the Clinical Trial Participant Compensation Exclusion Act aims to support and encourage participation in clinical trials, ultimately benefiting both individuals and the broader medical community.
The bill recognizes the important role that clinical trial participants play in advancing medical research and innovation. By excluding compensation received for participating in these trials from gross income, the bill seeks to incentivize more individuals to participate in clinical trials, ultimately leading to the development of new and improved medical treatments and therapies.
Under the provisions of the bill, compensation received by clinical trial participants for their time, travel expenses, and other related costs would not be subject to federal income tax. This would provide much-needed financial relief to individuals who volunteer for these trials and help remove a potential barrier to participation. Overall, the Clinical Trial Participant Compensation Exclusion Act aims to support and encourage participation in clinical trials, ultimately benefiting both individuals and the broader medical community.
Congressional Summary of HR 7090
This bill excludes from gross income, for income tax purposes, amounts received as payment or reimbursement for participation in an approved clinical trial (i.e., a trial conducted for the prevention, detection, or treatment of cancer or other life-threatening disease or condition). This includes amounts paid or reimbursed for meals, lodging, or travel expenses.
Read the Full Bill
Current Status of Bill HR 7090
Bill HR 7090 is currently in the status of Bill Introduced since January 25, 2024. Bill HR 7090 was introduced during Congress 118 and was introduced to the House on January 25, 2024. Bill HR 7090's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024
Bipartisan Support of Bill HR 7090
Total Number of Sponsors
2Democrat Sponsors
0Republican Sponsors
2Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
1Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 7090
Primary Policy Focus
TaxationAlternate Title(s) of Bill HR 7090
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
Comments
Sponsors and Cosponsors of HR 7090
Latest Bills
Providing amounts for the expenses of the Committee on Ethics in the One Hundred Nineteenth Congress.
Bill HRES 131December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Central Yukon Record of Decision and Approved Resource Management Plan".
Bill HJRES 106December 12, 2025
Expressing the sense of the House of Representatives in condemning the Government of the People's Republic of China for its harassment and efforts to intimidate American citizens and other individuals on United States soil with the goal of suppressing speech and narratives the People's Republic of China finds unwelcome.
Bill HRES 130December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "North Dakota Field Office Record of Decision and Approved Resource Management Plan".
Bill HJRES 105December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Miles City Field Office Record of Decision and Approved Resource Management Plan Amendment".
Bill HJRES 104December 12, 2025
Providing amounts for the expenses of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party in the One Hundred Nineteenth Congress.
Bill HRES 104December 12, 2025
Critical Access for Veterans Care Act
Bill S 1868December 12, 2025
OATH Act of 2025
Bill S 1665December 12, 2025
A bill to extend the authority for modifications to the Second Division Memorial in the District of Columbia.
Bill S 1353December 12, 2025
Saving Our Veterans Lives Act of 2025
Bill S 926December 12, 2025
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
Bill HR 7418March 18, 2024